-Bloomberg
Nevro Secures FDA Nod HFX iQ Spinal Cord Stimulation System For to Personalize Pain Treatment
The FDA approved Nevro Corp’s (NYSE:NVRO) Senza HFX iQ spinal cord stimulation (SCS) system. Senza HFX iQ is the first and…
Related Posts
You Can Now File Lawsuits Via NFT Airdrop In The UK: What Does This Mean?
Fabrizio D'Aloia, the founder of the Italian online gambling business Micrograme, has been given permission by the High Court of England and Wales to use an NFT drop to file lawsuits against defendants who prefer to remain anonymous, according to CoinDes
DZ Bank Upgrades Cisco Systems to Buy, Announces $100 Price Target
DZ Bank analyst Ingo Wermann upgrades Cisco Systems (NASDAQ:CSCO) from Hold to Buy and announces $100 price target.
Procter & Gamble Faces Challenges From Strong Dollar & Inflation, Says Analyst
Raymond James analyst Olivia Tong reiterated an Outperform rating on the shares of Procter & Gamble Co (NYSE:PG) and lowered the price…